Table 3.
The effect of PK, Omez, and indomethacin as such and in combination with PK or Omez on the gastric secretion of pylorous ligated mice.a
Mice | Gastric juice (ml) (6 h) | pH | Acid output (μEq/6 h) |
Experimental control | 0.85 ± 0.1 | 3.56 | 183.6 ± 6.8 |
Treated with PK | 0.7 ± 0.1 | 3.41 | 179.2 ± 4.6 |
Treated with indomethacin | 1.6 ± 0.2b | 2.3 | 256.6 ± 10.2a |
Treated with PK + indomethacin | 1.3 ± 0.1c | 3.46 | 206.2 ± 5.9c |
Treated with Omez | 0.75 ± 0.09 | 3.36 | 186.5 ± 6.8c |
Treated with Omez + indomethacin | 0.9 ± 0.12d | 3.25 | 173.6 ± 6.4c |
aUntreated and treated mice were subjected to pylorous ligation. The treatment groups were orally administered PK (20 mg/kg/day × 3 days), Omez (3 mg/kg/day × 3 days), indomethacin (18 mg/kg × 1 d) as such or along with PK and Omez at the designated doses. The values are mean ± SEM (n = 5). aP < 0.05, bP < 0.01 compared to the experimental control mice cP < 0.05, dP < 0.01 compared to the indomethacin-treated mice